financetom
Business
financetom
/
Business
/
Taysha Gene Therapies Insider Bought Shares Worth $2,062,500, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Taysha Gene Therapies Insider Bought Shares Worth $2,062,500, According to a Recent SEC Filing
Jun 4, 2025 1:10 AM

03:48 AM EDT, 06/04/2025 (MT Newswires) -- Paul B Manning, 10% Owner, on May 30, 2025, executed a purchase for 750,000 shares in Taysha Gene Therapies ( TSHA ) for $2,062,500. Following the Form 4 filing with the SEC, Manning has control over a total of 25,601,111 common shares of the company, with 25,601,111 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1806310/000141588925015480/xslF345X05/form4-06042025_010624.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Lufthansa reports drop in FY operating profit after cash-strapped 2024
Lufthansa reports drop in FY operating profit after cash-strapped 2024
Mar 5, 2025
BERLIN (Reuters) - Lufthansa's operating profit dropped by over a third in 2024, the airline said on Thursday, capping a difficult 2024 during which spiralling costs, limited airspace and delivery delays hit its profitability. Lufthansa had last year aimed for an operating margin of 8%. The group said it reached a much lower point of 4.4%, citing among the reasons...
Germany's DHL to cut 8,000 jobs this year after annual operating profit falls 7.2%
Germany's DHL to cut 8,000 jobs this year after annual operating profit falls 7.2%
Mar 5, 2025
(Reuters) - DHL unveiled plans on Thursday to lay off about 8,000 jobs this year as part of a strategy to save more than 1 billion euros ($1.08 billion) by 2027, after the German logistics giant reported a 7.2% fall in annual operating profit. The job cuts, representing more than 1% of the total workforce, will occur in the Post...
Merck KGaA sees forex-adjusted earnings growth of up to 8% this year
Merck KGaA sees forex-adjusted earnings growth of up to 8% this year
Mar 5, 2025
FRANKFURT (Reuters) - Merck KGaA on Thursday forecast currency-adjusted operating earnings growth of up to 8%, helped by demand for semiconductor chemicals and for lab equipment in biotech drug production. The German group said in a statement that 2025 earnings before interest, taxes, depreciation and amortisation (EBITDA), adjusted for special items, would likely reach between 6.1 billion euros ($6.6 billion)...
Galderma posts 9.3% sales growth in 2024
Galderma posts 9.3% sales growth in 2024
Mar 5, 2025
ZURICH (Reuters) - Swiss skincare firm Galderma on Thursday posted sales of $4.41 billion for 2024, up 9.3% from the same period a year earlier in constant currency terms. Galderma's results come almost a year after the company listed on the Swiss stock exchange in March 2024, and its owners have gradually placed more and more shares on the market....
Copyright 2023-2026 - www.financetom.com All Rights Reserved